Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.
暂无分享,去创建一个
T. Lakka | J. Salonen | T. Tuomainen | T. Lakka | J. Salonen | T. Heliö | K. Kontula | K. Nyyssönen
[1] Trip,et al. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease , 1998, British journal of haematology.
[2] T. Lakka,et al. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1998, American journal of epidemiology.
[3] Tzong-Shyuan Lee,et al. Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.
[4] J. Salonen,et al. Association between body iron stores and the risk of acute myocardial infarction in men. , 1998, Circulation.
[5] W. Sly,et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[6] D. M. Penny,et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] I. Bata,et al. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. , 1998, The Canadian journal of cardiology.
[8] S. Chakrabarti,et al. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. , 1998, Gastroenterology.
[9] C. Férec,et al. Phenotype-genotype correlation in haemochromatosis subjects , 1997, Human Genetics.
[10] W. Sly,et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Wolff,et al. The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.
[12] Jennifer J. Pointon,et al. Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.
[13] H. Parving,et al. Population based study of rates of multiple pregnancies in denmark, 1980-94 , 1997, BMJ.
[14] J. Salonen,et al. First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome , 1997, BMJ.
[15] W. Sly,et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with b2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells (degradationyGolgi processingyintracellular transportyironymajor histocompatibility complex class I protein) , 1997 .
[16] L. Jorde,et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. , 1996, The New England journal of medicine.
[17] M. C. Ellis,et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.
[18] W. Crosby,et al. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. , 1996, Clinica chimica acta; international journal of clinical chemistry.
[19] N. Asp,et al. Iron nutrition in health and disease. , 1996 .
[20] J. Salonen,et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men , 1995, BMJ.
[21] J. Gutteridge,et al. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material , 1995, FEBS letters.
[22] M. Mutanen,et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. , 1995, Circulation.
[23] P. Adams. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: An analysis of 255 heterozygotes , 1994, American journal of hematology.
[24] J. Salonen. The role of iron as a cardiovascular risk factor , 1993 .
[25] J. Kushner,et al. Screening for hemochromatosis. , 1993, The New England journal of medicine.
[26] H. Macdonald. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. , 1993, Circulation.
[27] O. Aruoma,et al. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.
[28] K Kontula,et al. A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.
[29] J. Sullivan. Heterozygous hemochromatosis as a risk factor for premature myocardial infarction. , 1990, Medical hypotheses.
[30] J. Tuomilehto,et al. WHO MONICA Project: assessing CHD mortality and morbidity. , 1989, International journal of epidemiology.
[31] A. Reunanen,et al. Prevalence of hemochromatosis in Finland. , 2009, Acta medica Scandinavica.
[32] G. Gross,et al. Evidence For a Role of Iron‐Catalyzed Oxidants in Functional and Metabolic Stunning in the Canine Heart , 1988, Circulation research.
[33] M. Skolnick,et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. , 1988, The New England journal of medicine.
[34] Salonen Jt. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1988 .
[35] J. Salonen,et al. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1988, Annals of clinical research.
[36] J. Salonen,et al. An automated colorimetric assay for urine nicotine metabolites: a suitable alternative to cotinine assays for the assessment of smoking status. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[37] M. Weisfeldt,et al. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. , 1987, Circulation.
[38] A. Sonnenberg,et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.